XML 31 R17.htm IDEA: XBRL DOCUMENT
v3.23.3

Stock Based Compensation Plan | 9 Months Ended
--- | ---
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract] |
Stock Based Compensation Plan | Note 11. Stock-Based Compensation Plan The Company maintains the 2021 Equity Incentive Plan, or the 2021 Plan, which provides for the granting of stock awards to employees, directors and consultants. Options granted under the 2021 Plan may be either incentive stock options or nonqualified stock options. Options granted under the 2021 Plan expire no later than 10 years from the date of grant. Options and restricted stock awards under the 2021 Plan generally vest over four years. Restricted stock units granted under the 2021 Plan generally vest in one year. As of September 30, 2023, there were 3.3 million shares of common stock available for issuance under the 2021 Plan. The Company maintains the 2021 Employee Stock Purchase Plan, or the ESPP, which allows eligible employees to purchase shares of the Company’s common stock at a discount through payroll deductions of up to 15% of their eligible compensation, subject to plan limitations. An offering period under the ESPP consists of four six-month purchase periods, unless otherwise determined by the Company. The eligible employees are able to purchase shares at 85% of the lower of the fair market value of the Company’s common stock on the first trading day of the offering period or on the purchase day. As of September 30, 2023, there were 0.5 million shares of common stock available for issuance under the ESPP. During the nine months ended September 30, 2023, 0.5 million shares were issued under the ESPP. Stock Options A summary of stock option activity is set forth below (shares in thousands):
|  | Options Outstanding |
|  |  |  |  | Weighted |  |  | Average |  |  | Aggregate |
|  |  |  |  | Average |  |  | Remaining |  |  | Intrinsic |
|  | Number of |  |  | Exercise |  |  | Contractual Life |  |  | Value |
|  | Options |  |  | Price |  |  | (In years) |  |  | (In thousands) |
Outstanding – December 31, 2022 |  |  | 3,896 |  |  | $ | 2.43 |  |  |  | 8.44 |  |  |  |
Granted |  |  | 1,805 |  |  |  | 0.86 |  |  |  |  |  |  |
Exercised |  |  | (6 | ) |  |  | 0.56 |  |  |  |  |  |  |
Forfeited |  |  | (646 | ) |  |  | 2.40 |  |  |  |  |  |  |
Expired |  |  | (297 | ) |  |  | 2.20 |  |  |  |  |  |  |
Outstanding – September 30, 2023 |  |  | 4,752 |  |  |  | 1.85 |  |  |  | 8.14 |  |  | $ | — |
Exercisable – September 30, 2023 |  |  | 2,213 |  |  |  | 1.93 |  |  |  | 7.33 |  |  |  | — |
The aggregate intrinsic value of options outstanding and exercisable are the difference between the exercise price of the options and the fair value of the Company’s common stock at September 30, 2023. During the nine months ended September 30, 2023 and 2022, the Company granted options with a weighted-average grant-date fair value of $0.63 per share an d $2.31 pe r share, respectively. During the nine months ended September 30, 2023, the intrinsic value of options exercised was de minimis. No options were exercised during the nine months ended September 30, 2022. The fair value of options is estimated at the grant date using the Black-Scholes option-pricing model with the following weighted-average assumptions:
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Expected term (in years) |  |  | 6.02 |  |  |  | 6.05 |  |  |  | 5.85 |  |  |  | 6.00 |
Expected volatility |  |  | 84.66 | % |  |  | 83.46 | % |  |  | 85.86 | % |  |  | 80.94 | %
Risk-free rate |  |  | 4.19 | % |  |  | 2.95 | % |  |  | 3.89 | % |  |  | 1.94 | %
Dividend yield |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Restricted Stock Awards The following table summarizes the Company’s restricted stock award activity (shares in thousands):
|  |  |  |  | Weighted |
|  |  |  |  | Average |
|  | Number of |  |  | Grant Date |
|  | Shares |  |  | Fair Value |
RSAs, unvested at December 31, 2022 |  |  | 105 |  |  | $ | 9.74 |
Vested |  |  | (36 | ) |  |  | 9.68 |
RSAs, unvested at September 30, 2023 |  |  | 69 |  |  |  | 9.78 |
The fair value of restricted stock awards vested during the nine months ended September 30, 2023 and 2022 was de minimis and $0.1 million, respectively. Restricted Stock Units The following table summarizes the Company’s restricted stock unit, or RSU, activity (shares in thousands):
|  |  |  |  | Weighted |
|  |  |  |  | Average |
|  | Number of |  |  | Grant Date |
|  | Shares |  |  | Fair Value |
RSU, unvested at December 31, 2022 |  |  | — |  |  | $ | — |
Granted |  |  | 1,345 |  |  |  | 0.51 |
RSU, unvested at September 30, 2023 |  |  | 1,345 |  |  |  | 0.51 |
Stock-Based Compensation The total stock-based compensation expense recorded in the unaudited condensed consolidated statements of operations and comprehensive loss was as follows (in thousands):
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Research and development |  | $ | 215 |  |  | $ | 359 |  |  | $ | 882 |  |  | $ | 1,047 |
General and administrative |  |  | 698 |  |  |  | 718 |  |  |  | 2,318 |  |  |  | 1,925 |
Total stock-based compensation expense |  | $ | 913 |  |  | $ | 1,077 |  |  | $ | 3,200 |  |  | $ | 2,972 |
As of September 30, 2023, there was approximately $6.7 million of stock-based compensation expense to be recognized over a weighted-average period of approximately 1.86 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration